C07D 245/00
Heterocyclic compounds containing rings of more than seven members having two nitrogen
Official title: Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
C07D245/00 (Heterocyclic compounds containing rings of more than seven members having two nitrogen) appears on 200 US grants and 171 published applications in this corpus.
Search patents in C07D- Granted patents
- 200
- Published applications
- 171
- Assignees
- 157
- Inventors
- 647
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 4 | 0 |
| 1981 | 2 | 0 |
| 1982 | 5 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 9 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 2 |
| 2003 | 6 | 3 |
| 2004 | 4 | 5 |
| 2005 | 3 | 7 |
| 2006 | 1 | 1 |
| 2007 | 5 | 11 |
| 2008 | 1 | 5 |
| 2009 | 8 | 14 |
| 2010 | 5 | 11 |
| 2011 | 2 | 5 |
| 2012 | 6 | 9 |
| 2013 | 7 | 8 |
| 2014 | 8 | 8 |
| 2015 | 10 | 9 |
| 2016 | 7 | 11 |
| 2017 | 9 | 8 |
| 2018 | 3 | 5 |
| 2019 | 5 | 5 |
| 2020 | 4 | 7 |
| 2021 | 6 | 11 |
| 2022 | 4 | 6 |
| 2023 | 7 | 6 |
| 2024 | 3 | 6 |
| 2025 | 5 | 6 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Macrocyclic compounds as proteasome inhibitors18 Nov 2025US 12,473,331 B2Cornell University
- Marking precursor with squaric acid coupling12 Aug 2025US 12,383,636 B2Telix Pharmaceuticals Limited
- Ras inhibitors12 Aug 2025US 12,384,750 B2Revolution Medicines, Inc.
- Workflow for generating compounds with biological activity against a specific biological target6 May 2025US 12,293,809 B2Insilico Medicine IP Limited
- 1,4-diazocane compound or salt thereof29 Apr 2025US 12,286,417 B2D. Western Therapeutics Institute, Inc.
- Novel equilibrative nucleoside transporter inhibitors and methods of making and using same12 Mar 2026US 2026/0069604 A1
- Ras inhibitors12 Feb 2026US 2026/0042740 A1Revolution Medicines, Inc.
- Labeling precursors with squaric acid coupling18 Sep 2025US 2025/0288702 A1Telix Pharmaceuticals Limited
- Syrbactin macrolactams and unnatural analogs as proteasome inhibitors for the treatment of multiple myeloma and chemoenzymatic synthesis thereof11 Sep 2025US 2025/0282818 A1University of Florida Research Foundation, Inc.
- Catalyst31 Jul 2025US 2025/0242335 A1The University of Manchester
Most cited
By later US patents
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds78US 6,759,554 B2Massachusetts Institute of Technology · 2004
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds72US 6,867,298 B2Massachusetts Institute of Technology · 2005
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds62US 7,115,784 B2Massachusetts Institute of Technology · 2006
- Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors60US 5,811,422 AThe DuPont Merck Pharmaceutical Company · 1998